171 related articles for article (PubMed ID: 38475894)
1. The efficacy and safety of deucravacitinib compared to methotrexate, in patients with vulvar lichen planus who have failed topical therapy with potent corticosteroids: a study protocol for a single-centre double-blinded randomised controlled trial.
Wijaya M; Fischer G; Saunderson RB
Trials; 2024 Mar; 25(1):181. PubMed ID: 38475894
[TBL] [Abstract][Full Text] [Related]
2. Apremilast for genital erosive lichen planus in women (the AP-GELP Study): study protocol for a randomised placebo-controlled clinical trial.
Skullerud KH; Gjersvik P; Pripp AH; Qvigstad E; Helgesen ALO
Trials; 2021 Jul; 22(1):469. PubMed ID: 34284808
[TBL] [Abstract][Full Text] [Related]
3. Vulvovaginal photodynamic therapy vs. topical corticosteroids in genital erosive lichen planus: a randomized controlled trial.
Helgesen AL; Warloe T; Pripp AH; Kirschner R; Peng Q; Tanbo T; Gjersvik P
Br J Dermatol; 2015 Nov; 173(5):1156-62. PubMed ID: 26189484
[TBL] [Abstract][Full Text] [Related]
4. Comparing quality of life in women with vulvovaginal lichen planus treated with topical and systemic treatments using the vulvar quality of life index.
Kherlopian A; Fischer G
Australas J Dermatol; 2023 May; 64(2):e125-e134. PubMed ID: 37036241
[TBL] [Abstract][Full Text] [Related]
5. Systemic therapy for vulval Erosive Lichen Planus (the 'hELP' trial): study protocol for a randomised controlled trial.
Simpson RC; Murphy R; Bratton DJ; Sydes MR; Wilkes S; Nankervis H; Dowey S; Thomas KS
Trials; 2016 Jan; 17():2. PubMed ID: 26729245
[TBL] [Abstract][Full Text] [Related]
6. Interventions for erosive lichen planus affecting mucosal sites.
Cheng S; Kirtschig G; Cooper S; Thornhill M; Leonardi-Bee J; Murphy R
Cochrane Database Syst Rev; 2012 Feb; 2012(2):CD008092. PubMed ID: 22336835
[TBL] [Abstract][Full Text] [Related]
7. Identifying predictors of systemic immunosuppressive treatment of vulvovaginal lichen planus: A retrospective cohort study of 122 women.
Kherlopian A; Fischer G
Australas J Dermatol; 2022 Aug; 63(3):335-343. PubMed ID: 35500127
[TBL] [Abstract][Full Text] [Related]
8. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Oral Methotrexate Therapy versus Systemic Corticosteroid Therapy in Treatment of Generalised Lichen Planus.
Bakhtiar R; Noor SM; Paracha MM
J Coll Physicians Surg Pak; 2018 Jul; 28(7):505-508. PubMed ID: 29950252
[TBL] [Abstract][Full Text] [Related]
10. Cepharanthine and Oral Lichen Planus Efficacy (COLE) study: protocol for a multicentre randomised controlled study assessing the efficacy and safety of cepharanthine with topical corticosteroids in oral lichen planus.
Yagyuu T; Isogawa M; Yamamoto K; Sugiura T; Matsusue Y; Kasahara M; Kirita T
BMJ Open; 2023 Aug; 13(8):e074279. PubMed ID: 37586860
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. A prospective observational study to compare efficacy of topical triamcinolone acetonide 0.1% oral paste, oral methotrexate, and a combination of topical triamcinolone acetonide 0.1% and oral methotrexate in moderate to severe oral lichen planus.
Chauhan P; De D; Handa S; Narang T; Saikia UN
Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29124831
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study.
Boch K; Langan EA; Zillikens D; Ludwig RJ; Kridin K
J Dermatol; 2021 Dec; 48(12):1913-1917. PubMed ID: 34668211
[TBL] [Abstract][Full Text] [Related]
15. Treatments for Cutaneous Lichen Planus: A Systematic Review and Meta-Analysis.
Atzmony L; Reiter O; Hodak E; Gdalevich M; Mimouni D
Am J Clin Dermatol; 2016 Feb; 17(1):11-22. PubMed ID: 26507510
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of photobiomodulation on oral lichen planus: a protocol study for a double-blind, randomised controlled clinical trial.
Ferri EP; Gallo CB; Abboud CS; Yanaguizawa WH; Horliana ACRT; Silva DFTD; Pavani C; Bussadori SK; Nunes FD; Mesquita-Ferrari RA; Fernandes KPS; Rodrigues MFSD
BMJ Open; 2018 Oct; 8(10):e024083. PubMed ID: 30297352
[TBL] [Abstract][Full Text] [Related]
17. Treatment of erosive vulvovaginal lichen planus with methotrexate.
Jang N; Fischer G
Australas J Dermatol; 2008 Nov; 49(4):216-9. PubMed ID: 18855784
[TBL] [Abstract][Full Text] [Related]
18. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
Lonsdale-Eccles AA; Velangi S
Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
[TBL] [Abstract][Full Text] [Related]
19. Photobiomodulation versus corticosteroid in the management of erosive oral lichen planus: a randomized controlled clinical trial.
Mohamed RK; Elsayed NM; Mahmoud SA; Gaweesh YY
BMC Oral Health; 2024 Feb; 24(1):246. PubMed ID: 38365694
[TBL] [Abstract][Full Text] [Related]
20. Erosive vulvar lichen planus: retrospective review of characteristics and outcomes in 113 patients seen in a vulvar specialty clinic.
Kennedy CM; Galask RP
J Reprod Med; 2007 Jan; 52(1):43-7. PubMed ID: 17286068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
